Edges in Network
Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | LY96 |
Upstream (Parents) |
---|
(<<) TYROBP → LY96 |
(<<) HLA-DRA → LY96 |
(<<) CD86 → LY96 |
(<<) RNASE6 → LY96 |
Downstream (Children) |
---|
LY96 → C7orf13 (>>) |
LY96 → RIPK4 (>>) |
LY96 → EIF3CL///EIF3C (>>) |
LY96 → MICAL3 (>>) |
LY96 → PECAM1 (>>) |
LY96 → ARL11 (>>) |
LY96 → SAT1 (>>) |
LY96 → C6orf168 (>>) |
LY96 → FCGR2B (>>) |
LY96 → TRIM45 (>>) |
LY96 → VANGL1 (>>) |
LY96 → CELSR2 (>>) |
LY96 → CCPG1 (>>) |
LY96 → ENTPD1 (>>) |
LY96 → EMP3 (>>) |